220 related articles for article (PubMed ID: 15714124)
1. Trends in incidence of various morphologies of malignant melanoma in Vaud and Neuchatel, Switzerland.
Levi F; Te VC; Randimbison L; La Vecchia C
Melanoma Res; 2005 Feb; 15(1):73-5. PubMed ID: 15714124
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
Garbe C; Orfanos CE
Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous malignant melanoma incidence and mortality trends in Canada: A comprehensive population-based study.
Ghazawi FM; Cyr J; Darwich R; Le M; Rahme E; Moreau L; Netchiporouk E; Zubarev A; Roshdy O; Glassman SJ; Sasseville D; Litvinov IV
J Am Acad Dermatol; 2019 Feb; 80(2):448-459. PubMed ID: 30092328
[TBL] [Abstract][Full Text] [Related]
4. Incidence trends and clinical-pathological characteristics of invasive cutaneous melanoma from 1980 to 2010 in the Canton of Zurich, Switzerland.
Minini R; Rohrmann S; Braun R; Korol D; Dehler S
Melanoma Res; 2017 Apr; 27(2):145-151. PubMed ID: 27926588
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland.
Levi F; Randimbison L; La Vecchia C; Te VC; Franceschi S
Int J Cancer; 1998 Oct; 78(3):315-9. PubMed ID: 9766565
[TBL] [Abstract][Full Text] [Related]
6. High constant incidence rates of second cutaneous melanomas.
Levi F; Randimbison L; Te VC; La Vecchia C
Int J Cancer; 2005 Dec; 117(5):877-9. PubMed ID: 15957164
[TBL] [Abstract][Full Text] [Related]
7. Opportunistic screening strategy for cutaneous melanoma does not change the incidence of nodular and thick lesions nor reduce mortality: a population-based descriptive study in the European region with the highest incidence.
Bordoni A; Leoni-Parvex S; Peverelli S; Mazzola P; Mazzucchelli L; Spitale A
Melanoma Res; 2013 Oct; 23(5):402-7. PubMed ID: 23839077
[TBL] [Abstract][Full Text] [Related]
8. Trends of skin cancer in the Canton of Vaud, 1976-92.
Levi F; Franceschi S; Te VC; Randimbison L; La Vecchia C
Br J Cancer; 1995 Oct; 72(4):1047-53. PubMed ID: 7547221
[TBL] [Abstract][Full Text] [Related]
9. Malignant melanoma of the head and neck in Scotland: an eight-year analysis of trends in prevalence, distribution and prognosis.
Cox NH; Jones SK; MacKie RM
Q J Med; 1987 Aug; 64(244):661-70. PubMed ID: 3444872
[TBL] [Abstract][Full Text] [Related]
10. Incidence and survival in patients with cutaneous melanoma by morphology, anatomical site and TNM stage: a Danish Population-based Register Study 1989-2011.
Bay C; Kejs AM; Storm HH; Engholm G
Cancer Epidemiol; 2015 Feb; 39(1):1-7. PubMed ID: 25468643
[TBL] [Abstract][Full Text] [Related]
11. Incidence of invasive cancers following cutaneous malignant melanoma.
Levi F; La Vecchia C; Randimbison L; Te VC; Erler G
Int J Cancer; 1997 Sep; 72(5):776-9. PubMed ID: 9311593
[TBL] [Abstract][Full Text] [Related]
12. Early detection of thick melanomas in the United States: beware of the nodular subtype.
Demierre MF; Chung C; Miller DR; Geller AC
Arch Dermatol; 2005 Jun; 141(6):745-50. PubMed ID: 15967921
[TBL] [Abstract][Full Text] [Related]
13. Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group.
Cox NH; Aitchison TC; Sirel JM; MacKie RM
Br J Cancer; 1996 Apr; 73(7):940-4. PubMed ID: 8611411
[TBL] [Abstract][Full Text] [Related]
14. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. The consequences of a reclassification of the original group of lentigo maligna melanomas.
Larsen TE; Grude TH
Acta Pathol Microbiol Scand A; 1979 Jul; 87A(4):255-60. PubMed ID: 474127
[TBL] [Abstract][Full Text] [Related]
15. Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.
van der Rhee JI; Krijnen P; Gruis NA; de Snoo FA; Vasen HFA; Putter H; Kukutsch NA; Bergman W
J Am Acad Dermatol; 2011 Aug; 65(2):281-288. PubMed ID: 21570156
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of incidence and clinical features of cutaneous malignant melanoma in Crete (Greece) and southern Germany (central Baden-Württemberg).
Lasithiotakis K; Leiter U; Krüger-Krasagakis S; Tosca A; Garbe C
Br J Dermatol; 2006 Jun; 154(6):1123-7. PubMed ID: 16704644
[TBL] [Abstract][Full Text] [Related]
17. Trends in skin cancer incidence in Vaud: an update, 1976-1998.
Levi F; Te VC; Randimbison L; Erler G; La Vecchia C
Eur J Cancer Prev; 2001 Aug; 10(4):371-3. PubMed ID: 11535880
[TBL] [Abstract][Full Text] [Related]
18. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. I. Histological classification, sex and age of the patients, localization of tumour and prognosis.
Larsen TE; Grude TH
Acta Pathol Microbiol Scand A; 1978 Sep; 86A(5):437-50. PubMed ID: 716905
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological characteristics of cutaneous malignant melanoma of the head and neck--a population-based study.
Gillgren P; Månsson-Brahme E; Frisell J; Johansson H; Larsson O; Ringborg U
Acta Oncol; 1999; 38(8):1069-74. PubMed ID: 10665765
[TBL] [Abstract][Full Text] [Related]
20. Melanoma in Western Australia in 1980-81: incidence and characteristics of histological types.
English DR; Heenan PJ; Holman CD; Armstrong BK; Blackwell JB; Kelsall GR; Matz LR; Singh A; Ten Seldam RE
Pathology; 1987 Oct; 19(4):383-92. PubMed ID: 3444664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
